Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Seidman

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Cardiac dysfunction in the trastuzumab clinical trials experienceAndrew Seidman, Clifford Hudis, Mary Kathryn Pierri, et al.
Cancer|June 22, 2010
A prospective evaluation of the durability of palliative interventions for patients with metastatic breast cancerMary Morrogh, Thomas J Miner, Anna Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Prospective exploratory analysis of the association between tumor response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for refractory metastatic breast cancerShanu Modi, Katherine S Panageas, Elaine T Duck, et al.
Journal of Cancer Research and Clinical Oncology|March 3, 2009
A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effectsGary Deng, Hong Lin, Andrew Seidman, et al.
Cancer|January 7, 2010
A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancerStacy L Moulder, Frankie A Holmes, Anthony W Tolcher, et al.
Cancer Immunology, Immunotherapy : CII|February 9, 2010
Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicityHong Lin, Elisa de Stanchina, Xi Kathy Zhou, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2014
Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgeryT Jonathan Yang, Jung Hun Oh, Michael R Folkert, et al.
JNCI Cancer Spectrum|November 23, 2020
Yoga for Chemotherapy-Induced Peripheral Neuropathy and Fall Risk: A Randomized Controlled TrialTing Bao, Iris Zhi, Raymond Baser, et al.
Journal of the American Geriatrics Society|July 27, 2006
A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapyArti Hurria, Anju Hurria, Enid Zuckerman, et al.
Neuro-Oncology Advances|January 7, 2022
Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasisN Ari Wijetunga, Adrienne Boire, Robert J Young, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Cardiac dysfunction in the trastuzumab clinical trials experienceAndrew Seidman, Clifford Hudis, Mary Kathryn Pierri, et al.
Cancer|June 22, 2010
A prospective evaluation of the durability of palliative interventions for patients with metastatic breast cancerMary Morrogh, Thomas J Miner, Anna Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Prospective exploratory analysis of the association between tumor response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for refractory metastatic breast cancerShanu Modi, Katherine S Panageas, Elaine T Duck, et al.
Journal of Cancer Research and Clinical Oncology|March 3, 2009
A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effectsGary Deng, Hong Lin, Andrew Seidman, et al.
Cancer|January 7, 2010
A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancerStacy L Moulder, Frankie A Holmes, Anthony W Tolcher, et al.
Cancer Immunology, Immunotherapy : CII|February 9, 2010
Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicityHong Lin, Elisa de Stanchina, Xi Kathy Zhou, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2014
Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgeryT Jonathan Yang, Jung Hun Oh, Michael R Folkert, et al.
JNCI Cancer Spectrum|November 23, 2020
Yoga for Chemotherapy-Induced Peripheral Neuropathy and Fall Risk: A Randomized Controlled TrialTing Bao, Iris Zhi, Raymond Baser, et al.
Journal of the American Geriatrics Society|July 27, 2006
A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapyArti Hurria, Anju Hurria, Enid Zuckerman, et al.
Neuro-Oncology Advances|January 7, 2022
Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasisN Ari Wijetunga, Adrienne Boire, Robert J Young, et al.
Pageof 3